$CNS Pharmaceuticals(CNSP)$ 8-K Current report, items 1.01, 8.01, and 9.01 Accession Number: 0001683168-20-004454 Act: 34 Size: 414 KB 网页链接
$CNS Pharmaceuticals(CNSP)$ 424B4 Prospectus [Rule 424(b)(4)] Accession Number: 0001683168-20-004442 Act: 33 Size: 228 KB 网页链接
$CNS Pharmaceuticals(CNSP)$ EFFECT Notice of Effectiveness Accession Number: 9999999995-20-003641 Act: 33 Size: 1 KB 网页链接
$CNS Pharmaceuticals(CNSP)$ S-1/A [Amend] General form for registration of securities under the Securities Act of 1933 Accession Number: 0001683168-20-004411 Act: 33 Size: 750 KB 网页链接
$CNS Pharmaceuticals(CNSP)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001683168-20-004395 Act: 34 Size: 82 KB 网页链接
$CNS Pharmaceuticals(CNSP)$ S-1 General form for registration of securities under the Securities Act of 1933 Accession Number: 0001683168-20-004391 Act: 33 Size: 693 KB 网页链接
$CNS Pharmaceuticals(CNSP)$ 8-K Current report, items 7.01 and 9.01 Accession Number: 0001683168-20-004263 Act: 34 Size: 7 MB 网页链接
$CNS Pharmaceuticals(CNSP)$ 8-K Current report, items 7.01 and 9.01 Accession Number: 0001683168-20-003855 Act: 34 Size: 7 MB 网页链接
$CNS Pharmaceuticals(CNSP)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001683168-20-003852 Act: 34 Size: 1 MB 网页链接
$CNS Pharmaceuticals(CNSP)$ 424B3 Prospectus [Rule 424(b)(3)] Accession Number: 0001683168-20-003389 Act: 33 Size: 216 KB 网页链接